COVID-19 Public Health Emergency ending; benefit modifications also ending
Blue Cross and Blue Shield of Kansas (BCBSKS) has worked with providers and members to ease some of the financial stress and burdens that arose during the COVID-19 pandemic. With the end of the Public Health Emergency coming up, we want to make sure you are aware that as of May 11, 2023, BCBSKS will return to normal benefits which will include members being responsible for cost share (co-pays, deductibles).
Effective May 11, 2023:
- COVID-19 testing and related services – Members will be responsible for their cost share, based on the member’s contract. BCBSKS will no longer be covering the full cost of testing.
- Please note: over the counter COVID-19 testing is not covered under member’s benefits.
- COVID-19 Vaccine, administration, and related E&M (99211, 99202) codes – Members will be responsible for their cost share, based on their member contract. BCBSKS will no longer be covering the full cost of vaccine, administration of vaccine, and related E&M (99211, 99202) codes.
- COVID-19 antibody infusion therapy treatment and administration – Members will be responsible for their cost share, based on their member contract. BCBSKS will no longer be covering the full cost of antibody infusion therapy treatment and administration.
- COVID-19 treatment – private room differential will return to normal private room benefits and coverage.
- Prime –
- Over the counter COVID-19 tests will no longer be covered.
- Reimbursement of vaccine administration will return to pre-covid rates.
- Dispensing fees will return to pre-covid amounts for the anti-viral drug Paxlovid.
If your patients have questions related to their COVID-19 coverage, they can visit our website.
If you have additional questions regarding the latest news article, please contact your BCBSKS provider representative/consultant.